ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,108,000 | -9.1% | 330,200 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $4,520,000 | +73.3% | 330,200 | -6.4% | 0.01% | +75.0% |
| Q2 2016 | $2,608,000 | +12.2% | 352,900 | -3.0% | 0.00% | 0.0% |
| Q1 2016 | $2,325,000 | -3.6% | 363,900 | -5.7% | 0.00% | 0.0% |
| Q4 2015 | $2,411,000 | +7.0% | 385,800 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,253,000 | -29.4% | 385,800 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $3,191,000 | +28.0% | 385,800 | 0.0% | 0.01% | +66.7% |
| Q1 2015 | $2,492,000 | 0.0% | 385,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,492,000 | +19.6% | 385,800 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,083,000 | -15.3% | 385,800 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $2,458,000 | -12.7% | 385,800 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $2,816,000 | +4.3% | 385,800 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $2,701,000 | -62.7% | 385,800 | -2.1% | 0.00% | -69.2% |
| Q3 2013 | $7,251,000 | +6.3% | 394,056 | +1.1% | 0.01% | -7.1% |
| Q2 2013 | $6,820,000 | – | 389,941 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |